18f-fdg Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Interventional (1)

Fudan University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadepidermal growth factor

I am/have/hadher1

I am/have/haderbb2

I am/have/hadadjuvant therapy

I am/have/hadcore needle biopsy

I am/have/hadher2+ breast cancer

I am/have/hadprimary tumor

I am/have/hadpertuzumab + trastuzumab

I am/have/hadbreast cancer

I am/have/hadejection fraction

I am/have/hadimmunohistochemistry

I am/have/hadepidermal growth factor receptor

I am/have/hadcancer

I am/have/hadher2 gene amplification

I am/have/hadHER2

added new label for I am/have/had

more

I am looking for

I am looking forepidermal growth factor

I am looking forgrowth factor

I am looking forerbb2

I am looking forpertuzumab

I am looking forher-2

I am looking fortrastuzumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

This study is to explore the markers in early prediction of the efficacy of pre-operative pertuzumab plus trastuzumab (PH) combined with chemotherapy for early stage or locally advanced human epidermal growth factor receptor-2 (HER-2) positive primary breast cancer.

epidermal growth factor

erbb2

breast cancer

immunohistochemistry

pertuzumab

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.